These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22517588

  • 1. Musashi 2 in hematopoiesis.
    de Andrés-Aguayo L, Varas F, Graf T.
    Curr Opin Hematol; 2012 Jul; 19(4):268-72. PubMed ID: 22517588
    [Abstract] [Full Text] [Related]

  • 2. Roles for MSI2 and PROX1 in hematopoietic stem cell activity.
    Hope KJ, Sauvageau G.
    Curr Opin Hematol; 2011 Jul; 18(4):203-7. PubMed ID: 21577104
    [Abstract] [Full Text] [Related]

  • 3. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.
    Kharas MG, Lengner CJ, Al-Shahrour F, Bullinger L, Ball B, Zaidi S, Morgan K, Tam W, Paktinat M, Okabe R, Gozo M, Einhorn W, Lane SW, Scholl C, Fröhling S, Fleming M, Ebert BL, Gilliland DG, Jaenisch R, Daley GQ.
    Nat Med; 2010 Aug; 16(8):903-8. PubMed ID: 20616797
    [Abstract] [Full Text] [Related]

  • 4. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
    Zhang H, Tan S, Wang J, Chen S, Quan J, Xian J, Zhang Ss, He J, Zhang L.
    Exp Cell Res; 2014 Jan 01; 320(1):119-27. PubMed ID: 24076374
    [Abstract] [Full Text] [Related]

  • 5. HOX and non-HOX homeobox genes in leukemic hematopoiesis.
    Owens BM, Hawley RG.
    Stem Cells; 2002 Jan 01; 20(5):364-79. PubMed ID: 12351808
    [Abstract] [Full Text] [Related]

  • 6. The molecular pathogenesis of acute myeloid leukemia.
    Steffen B, Müller-Tidow C, Schwäble J, Berdel WE, Serve H.
    Crit Rev Oncol Hematol; 2005 Nov 01; 56(2):195-221. PubMed ID: 16236521
    [Abstract] [Full Text] [Related]

  • 7. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F, Pisegna S, Diverio D.
    Haematologica; 1997 Nov 01; 82(3):364-70. PubMed ID: 9234595
    [Abstract] [Full Text] [Related]

  • 8. Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia.
    Kaeda J, Ringel F, Oberender C, Mills K, Quintarelli C, Pane F, Koschmieder S, Slany R, Schwarzer R, Saglio G, Hemmati P, van Lessen A, Amini L, Gresse M, Vagge E, Burmeister T, Serra A, Carson A, Schwarz M, Westermann J, Jundt F, Dörken B, le Coutre P.
    Leuk Lymphoma; 2015 Jul 01; 56(7):2105-13. PubMed ID: 25363400
    [Abstract] [Full Text] [Related]

  • 9. Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.
    Ganapati U, Tan HT, Lynch M, Dolezal M, de Vos S, Gasson JC.
    Stem Cells; 2007 Aug 01; 25(8):1872-80. PubMed ID: 17464091
    [Abstract] [Full Text] [Related]

  • 10. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
    Ye AF, Han YX, Zhang SH, Li HY, Chen CQ, Wu JB.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct 01; 22(5):1235-8. PubMed ID: 25338564
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of IRS2 in myelodysplastic syndrome: a possible role in impaired hematopoietic cell differentiation.
    Machado-Neto JA, Favaro P, Lazarini M, da Silva Santos Duarte A, Archangelo LF, Lorand-Metze I, Costa FF, Saad ST, Traina F.
    Leuk Res; 2012 Jul 01; 36(7):931-5. PubMed ID: 22465474
    [Abstract] [Full Text] [Related]

  • 12. Osteogenic niche in the regulation of normal hematopoiesis and leukemogenesis.
    Le PM, Andreeff M, Battula VL.
    Haematologica; 2018 Dec 01; 103(12):1945-1955. PubMed ID: 30337364
    [Abstract] [Full Text] [Related]

  • 13. PLAG1 and USF2 Co-regulate Expression of Musashi-2 in Human Hematopoietic Stem and Progenitor Cells.
    Belew MS, Bhatia S, Keyvani Chahi A, Rentas S, Draper JS, Hope KJ.
    Stem Cell Reports; 2018 Apr 10; 10(4):1384-1397. PubMed ID: 29641991
    [Abstract] [Full Text] [Related]

  • 14. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Testa U, Pelosi E.
    Leuk Lymphoma; 2015 May 10; 56(5):1466-74. PubMed ID: 25242094
    [Abstract] [Full Text] [Related]

  • 15. [Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].
    Baskaran D, Spirin PV, Prasolov VS.
    Mol Biol (Mosk); 2010 May 10; 44(3):418-30. PubMed ID: 20608165
    [Abstract] [Full Text] [Related]

  • 16. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
    Palacios F, Yan XJ, Ferrer G, Chen SS, Vergani S, Yang X, Gardner J, Barrientos JC, Rock P, Burack R, Kolitz JE, Allen SL, Kharas MG, Abdel-Wahab O, Rai KR, Chiorazzi N.
    Leukemia; 2021 Apr 10; 35(4):1037-1052. PubMed ID: 33504942
    [Abstract] [Full Text] [Related]

  • 17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 10; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 18. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
    Kastner P, Chan S.
    Int J Biochem Cell Biol; 2008 Jul 10; 40(1):22-7. PubMed ID: 17374502
    [Abstract] [Full Text] [Related]

  • 19. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L, Begley CG.
    Bioessays; 1997 Jul 10; 19(7):607-13. PubMed ID: 9230693
    [Abstract] [Full Text] [Related]

  • 20. The role of microRNAs in normal and malignant hematopoiesis.
    Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J.
    Eur J Haematol; 2010 Jan 01; 84(1):1-16. PubMed ID: 19744129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.